Ashwagandha acts on the brain through several pathways: it lowers cortisol by calming the body’s central stress-response system, mimics the brain’s main calming neurotransmitter, and appears to protect neurons from toxic protein buildup. These effects translate into measurable improvements in stress, sleep, memory, and attention, though they come with a notable trade-off some users experience.
How It Lowers Stress Hormones
The most well-documented brain effect of ashwagandha is its ability to dial down the stress-response system known as the HPA axis, the communication loop between your brain and adrenal glands that controls cortisol release. When this system is overactive, cortisol stays elevated, which contributes to anxiety, poor sleep, and brain fog. Ashwagandha appears to dampen this loop directly.
In one clinical trial, men taking ashwagandha saw a 23% drop in fasting morning cortisol levels, compared to just 0.5% in the placebo group. The supplement also reduced levels of DHEA-S, another marker of HPA axis overactivity, by about 8%. Lower cortisol doesn’t just mean less perceived stress. Chronically elevated cortisol impairs the brain regions involved in memory and emotional regulation, so bringing it down has downstream cognitive benefits.
GABA Mimicry and Calming Effects
Ashwagandha’s active compounds, called withanolides, act as agonists at GABA receptors in the brain. GABA is the nervous system’s primary “off switch,” the neurotransmitter that reduces neuronal excitability. When GABA receptors are activated, chloride ions flow into neurons, making them slightly less likely to fire. This is the same basic mechanism behind anti-anxiety medications and sleep aids, though ashwagandha’s effect is milder.
Lab studies show ashwagandha extract nearly doubled the gene expression of one type of GABA receptor at higher concentrations. This increased GABA activity shifts brain cells from the alert “relay mode” characteristic of wakefulness into the slower oscillation patterns associated with deep sleep. That’s why ashwagandha’s calming and sleep-promoting effects are closely linked: the same receptor activity drives both.
Measurable Improvements in Sleep
A systematic review and meta-analysis of five clinical trials, covering 372 adults, found that ashwagandha significantly improved multiple dimensions of sleep. People fell asleep faster, stayed asleep longer, spent less time awake in the middle of the night, and had better overall sleep efficiency. The effect on sleep onset latency and total sleep time showed zero statistical inconsistency across trials, meaning the results were remarkably consistent from study to study. Doses in these trials ranged from 120 to 600 mg per day, taken for 6 to 12 weeks.
Effects on Memory and Attention
Human trials consistently show cognitive improvements, though the specific gains depend on the dose, duration, and population studied. In one trial, 225 mg daily for 30 days improved word recall, reaction time, picture recognition accuracy, and executive function in healthy younger adults. Participants also reported less mental tension and fatigue. A separate study found that 600 mg of root extract over eight weeks improved memory, sustained attention, and processing speed in older adults with early signs of cognitive decline.
Some effects appear quickly. A 14-day trial using 1,000 mg per day showed improvements in cognitive and psychomotor performance in healthy men in their twenties. But most robust results come from studies lasting four to eight weeks, suggesting the brain benefits build with consistent use. Even at the 30-day mark, lower doses (225 to 400 mg) have produced measurable gains in cognitive flexibility, visual memory, and reaction time.
Neuroprotective Properties
Ashwagandha shows promise in protecting brain cells from damage caused by beta-amyloid, the toxic protein fragment that accumulates in Alzheimer’s disease. In lab studies using human neuronal cells, ashwagandha reduced how much beta-amyloid was absorbed into cells and appeared to promote its clearance. One mechanism involves maintaining levels of a protein receptor called PPAR-gamma, which helps immune cells in the brain engulf and remove amyloid deposits. Cells treated with beta-amyloid alone showed significant drops in this receptor; cells treated with both beta-amyloid and ashwagandha did not.
Ashwagandha also acts as an antioxidant and free radical scavenger, which matters because oxidative stress is one of the ways beta-amyloid kills neurons. Additionally, it inhibits the enzyme that breaks down acetylcholine, a neurotransmitter critical for learning and memory. This is the same mechanism targeted by several Alzheimer’s medications. These findings are mostly from cell and animal studies, so the direct applicability to human neurodegeneration isn’t yet confirmed, but the biological plausibility is strong.
The Emotional Blunting Trade-Off
A significant number of long-term users report a side effect that rarely appears in clinical trial data: emotional blunting or anhedonia, a flattened ability to feel pleasure or emotional connection. This isn’t just reduced anxiety. People describe losing motivation, feeling robotic, or noticing that positive emotions disappear while negative stress responses remain largely unchanged.
The likely mechanism involves ashwagandha’s effect on serotonin receptors. It appears to upregulate one type of serotonin receptor while downregulating another, a pattern similar to what happens with long-term SSRI antidepressant use. For people whose serotonin levels are already on the higher end, this shift can push them into a state of emotional numbness. Not everyone experiences this, and some people with genuinely low serotonin or high anxiety find the opposite: ashwagandha restores a sense of calm they were missing. But the risk of emotional flattening is worth knowing about, especially if you plan to take it for more than a few weeks.
Reports suggest the effect can linger for a period after stopping supplementation, though most people describe it resolving over time.
Dosage and What to Look For
Clinical trials have used doses ranging from 120 mg to 1,250 mg per day, but the most commonly studied range for brain-related benefits is 300 to 600 mg of root extract daily. An international psychiatric taskforce has provisionally recommended 300 to 600 mg of root extract standardized to 5% withanolides for anxiety. That withanolide percentage matters: it’s the concentration of the active compounds actually doing the work. Products vary widely, with some standardized to 1.5% and others to 5% or higher, so the total milligrams on the label don’t tell the full story.
KSM-66 (a root-only extract) and Shoden (a root and leaf extract with higher withanolide concentration) are the two most commonly studied formulations. Most cognitive benefits in trials emerged between two and eight weeks of daily use, with some acute effects detectable within hours of a single dose.